The need for innovative antimicrobial agents has become increasingly urgent due to the rise of antibiotic-resistant pathogens and the persistent threat of infections acquired during hospital stays.
Traditional antibiotics and antiseptics are often ineffective against these resilient microorganisms, leading to severe health complications and increased healthcare costs. Therefore, researchers are exploring alternative solutions that can effectively target and eliminate these harmful pathogens. A promising development is the creation of an intelligent “nanokiller” derived from a component of cinnamon essential oil, which offers a novel approach to combating these microbial threats.
A team of researchers from the Universitat Politècnica de València (UPV) and the CIBER de Bioingeniería, Biomaterials y Nanomedicine (CIBER-BBN) has harnessed the antimicrobial properties of cinnamaldehyde, a key component of cinnamon essential oil, to develop this innovative nanodevice. Their findings, published in the journal Biomaterials Advances, demonstrate the significant potential of this nanokiller in addressing various pathogenic microorganisms.
The newly developed nanodevice has shown remarkable efficacy against several dangerous pathogens, including Escherichia coli, Staphylococcus aureus, and Candida albicans. These pathogens are responsible for a range of infections, from foodborne illnesses and wastewater contamination to serious nosocomial infections. The ability to effectively eliminate these pathogens could revolutionise infection control in various settings, including healthcare facilities, food processing, and environmental management.
Escherichia coli, while typically harmless, includes strains that can cause severe abdominal cramps, acute diarrhoea, and vomiting. Staphylococcus aureus can lead to skin infections, bloodstream infections, osteomyelitis, and pneumonia. Candida albicans, a common fungus, is notorious for causing diseases such as candidemia and invasive candidiasis. The versatility of the nanokiller in targeting these diverse microorganisms highlights its potential as a comprehensive antimicrobial agent.
The team from the IDM-CIBER NanoSens group has outlined the practical applications of this nanokiller. “For example, we could create a spray, make a formulation based on water and other compounds, and apply it directly. We could make a water-based formulation in the field and spray it directly, like any pesticide today. And in hospitals, it could be applied on bandages, and we could even try to make a capsule that could be taken orally,” explains Andrea Bernardos, a researcher in the NanoSens group at the Inter-University Institute for Molecular Recognition Research and Technological Development (IDM).
The nanodevice’s efficacy is significantly higher compared to free cinnamaldehyde. The encapsulated form is approximately 52 times more effective against Escherichia coli, 60 times more effective against Staphylococcus aureus, and 7 times more effective against Candida albicans. This improvement is attributed to the reduced volatility of cinnamaldehyde when encapsulated in a porous silica matrix and the increased local concentration of the compound when released in the presence of microorganisms.
“The increase in the antimicrobial activity of the essential oil component is possible thanks to the decrease in its volatility due to its encapsulation in a porous silica matrix and the increase in its local concentration when released due to the presence of the microorganisms,” says Bernardos.
One of the most notable advantages of this nanokiller is its high antimicrobial activity at very low doses. The nanodevice enhances the properties of free cinnamaldehyde, reducing the biocidal dose by approximately 98% for bacterial strains (Escherichia coli and Staphylococcus aureus) and 72% for the yeast strain (Candida albicans).
“Moreover, this type of device containing natural biocides (such as essential oil components) whose release is controlled by the presence of pathogens could also be applied in fields such as biomedicine, food technology, agriculture, and many others,” concludes Ángela Morellá-Aucejo, also an IDM researcher at the Universitat Politècnica de València.
The development of this intelligent nanokiller represents a significant step forward in the fight against antibiotic-resistant pathogens and nosocomial infections. Its potential applications across various industries underscore the importance of continued research and innovation in antimicrobial technologies. By leveraging the natural properties of essential oils and advanced nanotechnology, this new approach could pave the way for more effective and sustainable antimicrobial strategies.
Author:
Kate Sivess-Symes
Content Producer and Writer
News
World First: Stem Cell Transplant Restores Vision in Multiple People
A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their cornea. The clinical trial, which took place in Japan, is the first of its kind in the world, [...]
Clinical Trial: Mushroom Supplement May Halt Prostate Cancer Growth
The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use of white button mushrooms reduces the type of cells that suppress the immune system and facilitate the [...]
Scientists propose drug-free method to combat antibiotic-resistant bacteria
Recent estimates indicate that deadly antibiotic-resistant infections will rapidly escalate over the next quarter century. More than 1 million people died from drug-resistant infections each year from 1990 to 2021, a recent study reported, with [...]
New study shows how salmonella tricks gut defenses to cause infection
A new UC Davis Health study has uncovered how Salmonella bacteria, a major cause of food poisoning, can invade the gut even when protective bacteria are present. The research, published in the Proceedings of the National Academy [...]
Chlamydia vaccine shows early promise in mice
An experimental vaccine has shown promise in protecting against the sexually transmitted disease chlamydia, researchers report. Lab mice given the vaccine were able to rapidly clear subsequent chlamydia infections, and were less likely to [...]
Contradictory Discovery: Our Innate Immune System May Fuel Cancer Development
MSK researchers discovered that the innate immune system’s chronic activation due to issues in the Mre11 complex can lead to cancer, highlighting new therapeutic targets. In addition to defending against pathogens, the body’s innate [...]
New study links circadian gene variants to winter depression
Findings suggest that PER3 gene variants prevent adrenal adaptation to winter daylight, leading to serotonin disruption and depression-like behaviors. A recent study in Nature Metabolism used humanized mice with modified PERIOD3 gene variants (P415A and H417R) [...]
Quantum Leap for MRI: Atomic Sensors Unlock New Imaging Potential
New atomic sensor technology enhances MRI quality control by tracking hyperpolarized molecules in real-time, with potential benefits for various scientific fields. Magnetic resonance imaging (MRI) is a fundamental tool in modern medicine, offering detailed [...]
MethylGPT unlocks DNA secrets for age and disease prediction
By harnessing advanced AI, MethylGPT decodes DNA methylation with unprecedented accuracy, offering new paths for age prediction, disease diagnosis, and personalized health interventions. In a recent study posted to the bioRxiv preprint* server, researchers developed a [...]
“Astonishing” – Scientists Unveil First Blueprint of the Most Complex Molecular Machine in Human Biology
Researchers unveil the inner mechanisms of the most intricate and complex molecular machine in human biology. Scientists at the Centre for Genomic Regulation (CRG) in Barcelona have developed the first comprehensive blueprint of the [...]
Breakthrough research reveals how to target malignant DNA in aggressive cancers
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments. In three groundbreaking papers published [...]
How bacteria trigger colon cancer
In a recent study published in Nature, scientists used murine models to investigate how certain bacteria, such as Escherichia coli strains that contain a polyketide synthase (pks) island encoding enzymes that produce colibactin genotoxin, could increase the [...]
Nanoparticles designed to trap and neutralise large amounts of SARS-CoV2
(Nanowerk News) Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus particles, both in liquid solutions and on the surface of [...]
Nanodiscs: What Are They and How Are They Shaping the Future of Medicine?
Nanodiscs are synthetic phospholipid particles with a distinct morphology and size that enhance their efficiency in drug delivery applications.1 First developed by Sligar et al. in the early 2000s, these model membrane systems measure around 10 [...]
New Discovery Reveals How Ovarian Cancer Starves Immune Cells
Researchers discovered that ovarian tumors hinder T cells’ energy supply by trapping a key protein, blocking lipid uptake. A new approach to reprogram T cells could enhance immunotherapy for aggressive cancers. Researchers at Weill Cornell [...]
Innovative Drug-Design Strategies to Overcome Antibacterial Resistance
Antibacterial resistance occurs when antibiotics fail to treat bacterial infections. This incidence is considered one of the top global health threats, stemming from the misuse or overuse of antibiotics in humans and animals.1 The [...]
